Nationwide Fund Advisors’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Nationwide Fund Advisors’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-21,028	Closed	-$1.88M	–	2744
2017 Q3	$1.88M	Buy	21,028 +1,659	+9%	+$126K	0.01%	1473
2017 Q2	$1.16M	Buy	19,369 +2,071	+12%	+$116K	﹤0.01%	1705
2017 Q1	$923K	Buy	17,298 +414	+2%	+$24.6K	﹤0.01%	1806
2016 Q4	$843K	Sell	16,884 -748	-4%	-$40.1K	﹤0.01%	1876
2016 Q3	$1.06M	Buy	17,632 +6,401	+57%	+$369K	﹤0.01%	1750
2016 Q2	$574K	Buy	11,231 +5,427	+94%	+$232K	﹤0.01%	2079
2016 Q1	$171K	Buy	5,804 +463	+9%	+$14.6K	﹤0.01%	2607
2015 Q4	$242K	Buy	5,341 +131	+3%	+$6.87K	﹤0.01%	2448
2015 Q3	$217K	Hold	5,210	–	–	﹤0.01%	2523
2015 Q2	$314K	Buy	5,210 +2,768	+113%	+$183K	﹤0.01%	2489
2015 Q1	$189K	Buy	+2,442	New	+$141K	﹤0.01%	2720

Other funds holding ONCE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Nationwide Fund Advisors's ONCE Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2017, closing a stake of 21,028 shares — an estimated $1.88M sold.

Nationwide Fund Advisors first reported a position in ONCE in Q1 2015 and held it in 11 quarters. The position peaked at $1.88M in Q3 2017. 160 funds tracked by Wall St. Rank hold ONCE as of Q4 2017.

Nationwide Fund Advisors reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
Nationwide Fund Advisors sold 21,028 Spark Therapeutics, Inc. Common Stock shares in Q4 2017, an estimated $1.88M.
Nationwide Fund Advisors first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 11 quarters.
Nationwide Fund Advisors's Spark Therapeutics, Inc. Common Stock position peaked at $1.88M in Q3 2017.
160 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.